Robert Koch Institut: Clinical Trials

4 trials sponsored by Robert Koch Institut, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 21Completed 1

Follow Robert Koch Institut: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proactive Automatized Lifestyle Intervention
Proactive Automatized Lifestyle intervention - Health Risk Behaviors
Not applicableCompletedUniversity Medicine Greifswald1752022-05-312023-07-03
Incidence of Diabetes After a COVID-19 Infection
no interventional study - COVID-19, Diabetes Mellitus
CompletedInGef - Institute for Applied Health Research Berlin GmbH1571342018-01-012024-03-25
A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine
FLU-v, adjuvanted FLU-v, Saline - Influenza
Phase 2CompletedPepTcell Limited1752016-08-012020-09-16
Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza
Masks, Masks & hand hygiene, Control - Influenza
Not applicableCompletedRobert Koch Institut3002009-01-012011-04-22

Conditions studied

Influenza, Human (2)  ·  COVID-19 (1)  ·  Diabetes Mellitus (1)  ·  Health Risk Behaviors (1)  ·  Post-Acute COVID-19 Syndrome (1)

Interventions

Hand Hygiene (1)  ·  Masks (1)  ·  Sodium Chloride (1)

Countries

Germany (3)  ·  Netherlands (1)

Top investigators

Christa Scheidt-Nave, Dr. (1)  ·  Jennis Freyer-Adam, Prof. Dr. (1)  ·  Jochen Schmitt, Prof. Dr. med. (1)  ·  Josephine Jacob, MSc (1)  ·  Lukas Reitzle, Dr. (1)  ·  Paul Groeneveld, PhD (1)  ·  Ulrich John, Prof. Dr. (1)

Results publications

PMID 22280120, PMID 32150750, PMID 33215698, PMID 36123081, PMID 36715243, PMID 39425090, PMID 40101761, PMID 40988066

NIH funding

2015 (1)